Thank you for your interest
Listen to the Podcast below or view a Transcript of the Podcast here
Targeting the Hypoxic Tumor Microenvironment
Stephen Cary, Ph.D., Co-Founder & CEO, Omniox
In this podcast from CHI on September 20, 2017, Stephen Carey speaks about Omniox’s quest to deliver oxygen into the tumor microenvironment to improve immunotherapy response. He also remarks on the challenges facing tumor microenvironment research and strategies to overcome them. To see him in person, check out the Targeting the Tumor Microenvironment conference, part of ImPACT: Immunotherapy Progress and Clinical Treatments this December 5-7, 2017 in San Diego, CA.
For more information, please visit ImPACTImmunotherapy.com/Tumor-Microenvironment/